Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 11(1): 16629, 2021 08 17.
Artigo em Inglês | MEDLINE | ID: mdl-34404832

RESUMO

Since understanding molecular mechanisms of SARS-CoV-2 infection is extremely important for developing effective therapies against COVID-19, we focused on the internalization mechanism of SARS-CoV-2 via ACE2. Although cigarette smoke is generally believed to be harmful to the pathogenesis of COVID-19, cigarette smoke extract (CSE) treatments were surprisingly found to suppress the expression of ACE2 in HepG2 cells. We thus tried to clarify the mechanism of CSE effects on expression of ACE2 in mammalian cells. Because RNA-seq analysis suggested that suppressive effects on ACE2 might be inversely correlated with induction of the genes regulated by aryl hydrocarbon receptor (AHR), the AHR agonists 6-formylindolo(3,2-b)carbazole (FICZ) and omeprazole (OMP) were tested to assess whether those treatments affected ACE2 expression. Both FICZ and OMP clearly suppressed ACE2 expression in a dose-dependent manner along with inducing CYP1A1. Knock-down experiments indicated a reduction of ACE2 by FICZ treatment in an AHR-dependent manner. Finally, treatments of AHR agonists inhibited SARS-CoV-2 infection into Vero E6 cells as determined with immunoblotting analyses detecting SARS-CoV-2 specific nucleocapsid protein. We here demonstrate that treatment with AHR agonists, including FICZ, and OMP, decreases expression of ACE2 via AHR activation, resulting in suppression of SARS-CoV-2 infection in mammalian cells.


Assuntos
Enzima de Conversão de Angiotensina 2/antagonistas & inibidores , Fatores de Transcrição Hélice-Alça-Hélice Básicos/agonistas , Tratamento Farmacológico da COVID-19 , Carbazóis/farmacologia , Omeprazol/farmacologia , Receptores de Hidrocarboneto Arílico/agonistas , Enzima de Conversão de Angiotensina 2/genética , Enzima de Conversão de Angiotensina 2/metabolismo , Animais , Fatores de Transcrição Hélice-Alça-Hélice Básicos/metabolismo , COVID-19/virologia , Carbazóis/uso terapêutico , Chlorocebus aethiops , Citocromo P-450 CYP1A1/metabolismo , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Regulação da Expressão Gênica/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Células Hep G2 , Humanos , Omeprazol/uso terapêutico , RNA-Seq , Receptores de Hidrocarboneto Arílico/metabolismo , SARS-CoV-2/efeitos dos fármacos , SARS-CoV-2/patogenicidade , Transdução de Sinais/efeitos dos fármacos , Células Vero , Internalização do Vírus/efeitos dos fármacos
2.
J Anesth ; 25(1): 104-7, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21052735

RESUMO

Both severe hypokalemia and persistent hypertension are clinical symptoms of hyperaldosteronism. Hyperaldosteronism may occur as a primary or secondary syndrome. Excess ACTH produced ectopically by tumors may induce hyperaldosteronism through the mineralocorticoid activity of glucocorticoids that are upregulated by ACTH. Licorice, with the active ingredient glycyrrhiza, is also a well-known inducer of hyperaldosteronism under specific conditions. In this report, we describe a case of severe hypokalemia caused by ectopic ACTH syndrome (EAS) elicited by an intrathoracic carcinoid tumor, which had transformed to produce ACTH during the 6-year clinical course, and was modulated by licorice ingestion. Hypokalemia was not clearly recognized preoperatively but became obvious within 3 h of general anesthesia with epidural blockade. At the end of anesthesia, arterial blood gas analysis indicated severe hypokalemia ([K(+)] = 1.7 mEq/l) and metabolic alkalosis (pH 7.56, PaCO(2) = 54.9 mmHg, HCO(3)(-) = 44.5 mmol/l, BE = 21.8 mmol/l), without any typical symptoms such as muscle weakness or ECG abnormalities. The hypokalemia was resistant to potassium supplementation and persisted for 4 days. Perioperative imbalance between the administration and elimination of potassium and surgical stress might contribute to the rapid exacerbation and induce the clinical manifestation of EAS.


Assuntos
Síndrome de ACTH Ectópico/diagnóstico , Hipertensão/diagnóstico , Hipopotassemia/diagnóstico , Síndrome de ACTH Ectópico/complicações , Adjuvantes Anestésicos , Anestesia , Anestésicos Intravenosos , Gasometria , Pressão Sanguínea/fisiologia , Tumor Carcinoide/complicações , Tumor Carcinoide/cirurgia , Fentanila , Frequência Cardíaca/fisiologia , Hormônios/sangue , Humanos , Hipertensão/complicações , Hipopotassemia/complicações , Masculino , Pessoa de Meia-Idade , Nicardipino , Período Perioperatório , Piperidinas , Pneumonia por Pneumocystis/complicações , Transtornos Psicóticos/etiologia , Remifentanil , Neoplasias Torácicas/complicações , Neoplasias Torácicas/cirurgia , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA